Literature DB >> 25578420

The first case of breast cancer in thalassemic patient: case report and review of literature.

E Picardo1, M Mitidieri, E Minniti, S Ambroggio, F D'Addato, C Benedetto, G Gregori, M G Baù.   

Abstract

Thalassemias are genetic disorders characterized by decreased synthesis of one of the globin chains. Beta-thalassemia is caused by impairment in the production of beta-globin chains leaving the excess alpha chains unstable. With better treatment approaches and improvement in chelation therapy, thalassemic patients are living longer. As a consequence, new complications and associations with other conditions including malignancy have emerged. The occurrence of malignancies in thalassemia has rarely been reported, and our review of the literature revealed only few cases. We report the first case of a thalassemic patient developing breast cancer and discuss the possibility of a link between the two disease entities. This case is intended to alert physicians of the possibility of a malignancy in thalassemia patients.

Entities:  

Keywords:  Breast; cancer; estrogens; hormone replacement therapy

Mesh:

Substances:

Year:  2015        PMID: 25578420     DOI: 10.3109/09513590.2014.998646

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  1 in total

Review 1.  Review and Recommendations on Management of Adult Female Thalassemia Patients with Hypogonadism based on Literature Review and Experience of ICET-A Network Specialists.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Alice Albu; Soad Al Jaouni; Salvatore Anastasi; Maria Grazia Bisconte; Duran Canatan; Soteroula Christou; Shahina Daar; Salvatore Di Maio; Mohamed El Kholy; Doaa Khater; Mohamed Elshinawy; Yurdanur Kilinc; Roberto Mattei; Hala H Mosli; Alessandra Quota; Maria Grazia Roberti; Praveen Sobti; Saif Al Yaarubi; Saveria Canpisi; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.